Gene therapies, whereby a therapeutic gene is inserted into a patient’s cells, have shown massive promise to treat and prevent different diseases. Along with the development of the actual gene, the development of a safe and efficient delivery system is of equally high importance.

Join us for this luncheon seminar as three of our scientists, Drs. Andrew Hanneman, Christopher Sucato and Ian Parsons, discuss the analytical methods used to characterize gene therapies including delivery vectors such as recombinant adeno-associated viruses (rAAVs) and lentiviruses. Don’t miss the opportunity to be part of this interactive session that includes lunch, plenty of discussions and a certificate of completion for those that attend.

Topics and Speakers

Mass Spectrometry Assays for the Characterization of AAV Gene Delivery Vectors
Andrew Hanneman, Associate Director, Mass Spectrometry

Analytical Methods for Characterization and Release Testing of Gene Therapy Products
Ian Parsons, Director, Analytical Development

Analytical Ultracentrifugation Assays for the Characterization of Purity in AAV Gene Delivery Vectors
Christopher Sucato, Senior Scientist, Biophysical Characterization

For more information or to register today, visit our event webpage!